Associate, QC Microbiology, Cell Therapy at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Bachelor's degree preferred in science. Associate degree with equivalent combination of education and work experience may be considered. Netherlands: MLO level 4 or higher preferred, equivalent combination of education and work experience may be considered
0-2+ years of relevant microbiological testing or QC experience or equivalent combination of education and experience, preferably in a regulated environment
Demonstrated experience with basic laboratory techniques and basic laboratory safety practices
Prior experience with microbiological techniques is preferred
Ability to accurately and completely understand and follow procedures
Apply scientific principles to QC testing and the proper use of laboratory equipment
Ability to communicate effectively with peers and management regarding task completion, roadblocks, and needs
Attention to detail and demonstrated organizational skills
Ability to work in a fast-paced team environment, meet deadlines, and prioritize work

Responsibilities

Perform routine testing of in-process, final product, and stability samples
Perform environmental/facilities monitoring and microbiological testing
May review GMP documentation and perform data verification
Support document revision, project, CAPA and deviation/investigation related tasks and/or continuous improvement efforts
May train analysts on general job duties
Perform other tasks as assigned

Skills

QC Microbiology

GMP

Microbiological Testing

Environmental Monitoring

Laboratory Equipment

Data Verification

CAPA

Deviations

Investigations

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free